Dechra Pharmaceuticals PLC — AGM Information 2015

Oct 23, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3103D

Dechra Pharmaceuticals PLC

23 October 2015

Date: 23 October 2015

Dechra® Pharmaceuticals PLC

Results of Annual General Meeting (AGM)

AGM Meeting Date: 1 pm on 23 October 2015

Issued Share Capital at meeting date: 88,004,736

Number of shareholders in attendance: 13

All resolutions were passed on a show of hands.

Details of the proxy voting instructions lodged prior to the AGM are set out below:

Resolution (No. as noted on proxy form)	Total For (1)		Total Against		Withheld (2)
	No. of votes	% of vote	No. of votes	% of vote	No. of votes
Resolution 1: To receive the report and accounts	69,312,309	99.95	37,000	0.05	328,170
Resolution 2: To receive and approve the Directors' Remuneration Report	69,175,413	99.43	394,203	0.57	107,863
Resolution 3: To declare a final dividend	69,580,648	100	0	0.00	96,831
Resolution 4: To re-elect Michael Redmond	69,495,799	99.85	106,651	0.15	75,029
Resolution 5: To re-elect Ian Page	69,436,859	99.77	163,341	0.23	77,279
Resolution 6: To re-elect Anne-Francoise Nesmes	69,434,350	99.76	165,850	0.23	77,279
Resolution 7: To re-elect Anthony Griffin	69,375,878	99.77	163,341	0.20	138,260
Resolution 8: To re-elect Ishbel Macpherson	69,539,681	99.91	60,519	0.09	77,279
Resolution 9: To re-elect Dr Christopher Richards	69,185,096	99.40	415,104	0.60	77,279
Resolution 10: To re-elect Julian Heslop	69,567,164	99.95	33,036	0.05	77,279
Resolution 11: To re-appoint PricewaterhouseCoopers as Auditor	69,507,649	99.90	72,999	0.10	96,831
Resolution 12: To authorise the Directors to determine the remuneration of the Auditor	69,487,526	99.87	93,122	0.13	96,831
Resolution 13: To grant authority to allot shares to a specific limit	69,382,108	99.72	194,166	0.28	101,205
Resolution 14: To disapply pre-emptive rights	67,969,262	97.66	1,632,064	2.34	76,153
Resolution 15: To grant authority to the Company to purchase its own shares	69,517,584	99.89	76,551	0.11	83,344
Resolution 16: To call general meetings (other than an AGM) on not less than 14 clear days notice	66,672,572	95.79	2,927,628	4.21	77,279
Resolution 17: To adopt New Articles of Association	69,568,882	99.98	11,766	0.02	96,831

Notes

1.   Includes discretionary votes

2.   A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution

3.   Resolutions 1 to 13 were ordinary resolutions, requiring more than 50% of shareholder votes to be "for" the resolutions.

4.   Resolutions 14 to 17 were special resolutions, requiring more than 75% of shareholder votes to be "for" the resolutions.

5.   Votes tendered in respect of 69,677,479 shares representing 79.17% of the issued share capital

In accordance with Listing Rule 9.6.2R, a copy of the resolutions passed as special business at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

For further information

Rob Lamb, Company Secretary                

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGEASEDADLSFFF